Other studies have shown that PD-L1 expression on DCs from peripheral blood and tumor tissues can be ≥20 times higher than B7-1, and PD-L1 can bind B7.1 in cis, limiting B7.1’s interaction with T-cell CD28 and weakening T-cell activation [60]. This evidence concerns the gene CD28 and neoplasm.